• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616373)   Today's Articles (60)   Subscriber (49394)
For: Shigemura K, Osawa K, Mukai A, Yoshida H, Fujisawa M, Arakawa S. Anti-MRSA drug use and antibiotic susceptibilities of MRSA at a university hospital in Japan from 2007 to 2011. J Antibiot (Tokyo) 2013;66:273-6. [PMID: 23531989 DOI: 10.1038/ja.2013.14] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Number Cited by Other Article(s)
1
Mondal SK, Alam SA, Roymahapatra G, Mandal SM. Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound. J Antibiot (Tokyo) 2024:10.1038/s41429-024-00747-x. [PMID: 38890385 DOI: 10.1038/s41429-024-00747-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 04/25/2024] [Accepted: 05/15/2024] [Indexed: 06/20/2024]
2
Lade H, Kim JS. Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus. Antibiotics (Basel) 2021;10:398. [PMID: 33917043 PMCID: PMC8067735 DOI: 10.3390/antibiotics10040398] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 04/02/2021] [Accepted: 04/05/2021] [Indexed: 12/17/2022]  Open
3
An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. J Infect Chemother 2021;27:972-976. [PMID: 33618976 DOI: 10.1016/j.jiac.2021.02.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 02/01/2021] [Accepted: 02/08/2021] [Indexed: 11/21/2022]
4
A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa. J Infect Chemother 2018;24:949-953. [PMID: 30268412 DOI: 10.1016/j.jiac.2018.08.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Revised: 07/24/2018] [Accepted: 08/03/2018] [Indexed: 12/24/2022]
5
Takemura H, Mochizuki T. Comparison between local and national epidemiology of antimicrobial resistance using the JANIS data. J Infect Chemother 2018;24:868-872. [PMID: 30243900 DOI: 10.1016/j.jiac.2018.08.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2018] [Revised: 08/17/2018] [Accepted: 08/20/2018] [Indexed: 02/07/2023]
6
Gladstone BP, Cona A, Shamsrizi P, Vilken T, Kern WV, Malek N, Tacconelli E. Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use. PLoS One 2017;12:e0181358. [PMID: 28727741 PMCID: PMC5519079 DOI: 10.1371/journal.pone.0181358] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2017] [Accepted: 06/15/2017] [Indexed: 11/25/2022]  Open
7
Shiina M, Suga T, Asami Y, Nonaka K, Iwatsuki M, Omura S, Shiomi K. Euvesperins A and B, new circumventors of arbekacin resistance in MRSA, produced by Metarhizium sp. FKI-7236. J Antibiot (Tokyo) 2016;69:719-22. [PMID: 26758491 DOI: 10.1038/ja.2015.140] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2015] [Revised: 11/27/2015] [Accepted: 12/05/2015] [Indexed: 11/09/2022]
8
Shigemura K, Osawa K, Yamamichi F, Tanaka K, Tokimatsu I, Arakawa S, Fujisawa M. Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients. Int Urol Nephrol 2015;47:887-91. [DOI: 10.1007/s11255-015-0973-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Accepted: 03/30/2015] [Indexed: 11/28/2022]
9
Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin. J Antibiot (Tokyo) 2015;68:741-7. [PMID: 25990952 DOI: 10.1038/ja.2015.61] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 04/14/2015] [Accepted: 04/20/2015] [Indexed: 11/09/2022]
10
Ramsey DM, Amirul Islam M, Turnbull L, Davis RA, Whitchurch CB, McAlpine SR. Psammaplysin F: A unique inhibitor of bacterial chromosomal partitioning. Bioorg Med Chem Lett 2013;23:4862-6. [DOI: 10.1016/j.bmcl.2013.06.082] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2013] [Revised: 06/17/2013] [Accepted: 06/27/2013] [Indexed: 12/29/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA